AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by U.S. regulators, the company said on Friday.
AstraZeneca’s U.S. trial was paused on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company’s UK trial.
U.S. Health and Human Services Deputy Chief of Staff Paul Mango also told reporters he was optimistic a U.S. trial by Johnson & Johnson would resume. J&J paused its large, late-stage trial last week after a study participant became ill and the company said an independent safety panel was investigating.
AstraZeneca trials in the United Kingdom, Brazil and South Africa resumed last month even as the U.S. Food and Drug Administration continued its investigation into the case. Reuters earlier this week reported that the FDA had completed its review and that the AstraZeneca U.S. trial was set to resume as early as this week, citing four sources familiar with the situation.Reporting by Munsif Vengattil and Carl O’Donnell; Editing by Anil D’Silva, Rosalba O’Brien and Grant McCool
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Covid-19 vaccine volunteer in Brazil's AstraZeneca trial diesA volunteer in Brazil's trial of AstraZeneca's experimental coronavirus vaccine has died, the Brazilian health agency Anvisa announced on Wednesday, but organizers said there was no reason to stop the trial -- an indication that the death is not linked to the vaccine.
Weiterlesen »
WSJ News Exclusive | Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S.Covid-19 vaccine trial From AstraZeneca PLC and the University of Oxford can resume in U.S., according to a person familiar with the matter.
Weiterlesen »
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Weiterlesen »
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Weiterlesen »
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Weiterlesen »
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Weiterlesen »